SAN JOSE, Calif. , March 17, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX ), a biotechnology company focused on the treatment and prevention of cancer, today announced that its Chairman and Chief Executive Officer, Dr.
Amit Kumar , will be presenting at the 2025 Cancer Advocacy Group of Louisiana ("CAGLA") NeauxCancer Conference taking place on March 27-29, 2025 at the The Roosevelt Hotel in New Orleans . Dr. Kumar's presentation will provide an overview of Anixa's pioneering programs in cancer treatment, including updates on its cutting-edge CAR-T therapy for solid tumors and its novel cancer vaccine initiatives.
He will discuss the Company's latest progress in clinical development and how Anixa is advancing next-generation immunotherapies to transform cancer care. Details of the presentation are as follows: Event: 2025 CAGLA NeauxCancer Conference Date: March 28, 2025 Time: 10:00 AM CDT Location: The Roosevelt New Orleans Webcast: CAGLA 2025 Livestreams The CAGLA NeauxCancer Conference is a premier gathering of leading oncology researchers, industry executives, investors and medical professionals focused on groundbreaking developments in cancer treatment and care. For more information about the conference, visit https://cag-la.
org/neauxcancer-2025/ . About Anixa Biosciences, Inc. Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer.
Anixa's therapeutic portfolio consists of an ovarian canc.
